Planned sales, announced before they happen
1 trading plan running, 9 Form 144 notices for $10.8M
Plans running now
1
Michael J. Baughman
What EMR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Michael J. Baughman Executive Vice President, Chief Financial Officer and Chief Accounting Officer |
Adopted 10b5-1 plan | Sep 11, 2026 | up to 5,347 | May 10, 2027 | 10-K Nov 9, 2026 |
What the company wroteMichael J. Baughman, our Executive Vice President, Chief Financial Officer and Chief Accounting Officer, adopted a written 10b5-1 trading plan on September 11, 2026, during an open trading window. The plan’s maximum duration is until May 10, 2027. The first trade will not occur until December 11, 2026, at the earliest. The trading plan is intended to permit Mr. Baughman to sell up to 100 percent of the shares received upon the exercise and net settlement of options covering 5,347 shares of our common stock. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Karsanbhai Surendralal Lanca Officer, Director |
9,650 | $1.6M | Vesting Performance Share Award | none given | 9,650 shares from Aug 11, 2026 |
| Aug 6, 2026 | Michael H. Train Officer |
7,329 | $1.2M | Stock Option | none given | 7,329 shares from Aug 6, 2026 |
| Jun 1, 2026 | Krishnan Ram R. Director |
11,500 | $1.6M | Stock Award | none given | 11,500 shares from Jun 1, 2026 |
| Feb 12, 2026 | Karsanbhai Surendralal Lanca Officer, Director |
22,500 | $3.3M | Vesting of Performance Share Award; Vesting of Restricted Stock Award | none given | none found |
| Feb 10, 2026 | LEVATICH MATTHEW S Director |
1,476 | $224K | Restricted Stock Vesting | none given | none found |
| Feb 9, 2026 | Piazza Nicholas J. Officer |
6,703 | $1.1M | Equity Compensation; Restricted Stock Award | none given | none found |
| Feb 5, 2026 | BLINN MARK A Director |
2,876 | $439K | Restricted Stock Units | none given | none found |
| Dec 1, 2025 | SurendralalKarsanbhal Officer |
5,454 | $730K | stock award | none given | none found |
| Dec 1, 2025 | Surendralal Karsanbhal Officer |
4,773 | $640K | stock award | none given | none found |
Show the other 1 notices
From the Form 144 XML filed with the SEC, since Dec 1, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.